Want to track NOV and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 52 days
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
 NOV Novo Nordisk A/S 4 Feb 2026 (In 1 month) | | 5.93 | - |
| NOV Novo Nordisk A/S 5 Nov 2025 | | 4.95 | - |
| NOV Novo Nordisk A/S 6 Aug 2025 | | 6.05 | - |
| NOV Novo Nordisk A/S 30 Apr 2025 | | - | - |
| NOV Novo Nordisk A/S 5 Feb 2025 | | - | - |
| NOV Novo Nordisk A/S 6 Nov 2024 | | - | - |
| NOV Novo Nordisk A/S 7 Aug 2024 | | - | - |
| NOV Novo Nordisk A/S 3 May 2024 | | - | - |
NOV Earnings Reports FAQ
What is the earnings per share (EPS) for NOV?
The current EPS is 0.
What is the company's earnings growth rate?
Over the past 1 years, the earnings growth rate has been approximately -20.91%, reflecting the NOV's performance and XETRA market conditions.
When is the next earnings release date?
The next earnings release is expected to be on 2026-02-04, based on the NOV's typical earnings announcement schedule.
What were the most recent quarterly earnings?
The most recent quarterly earnings were 0.6028 per share, reported on 2025-11-05. For dividend history, visit the NOV Dividends page.
What is the price-to-earnings (P/E) ratio?
The price-to-earnings (P/E) ratio is 71.47, calculated based on the most recent stock price of €43.08.
2025 © Marketlog. All Rights Reserved.
